Indications of Intravenous Immunoglobulin Use

Project Title Indications of Intravenous Immunoglobulin Use
Date Posted
Friday, May 20, 2016

Modular program-based one-time assessment of the indications for use of intravenous immunoglobulin products. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2006 to June 30, 2012.  Modular programs are adaptable standardized programs. Results were generated using Modular Program 7; click here for more information.  Queries were distributed in February 2013. This report includes data from 18 Data Partners.
If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
intravenous immunoglobulin (IVIg)
Time Period
January 1, 2006 -July 30, 2012
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
Scroll to Top